The idea to examine the role of the p53LCs in cancer cell survival and proliferation stemmed from our initial observation of a germline p53 mutation in a man with an independent history of prostate, renal, thyroid, and lung cancers. This evidence concerns the gene TP53 and lung carcinoma.